CO6400200A2 - Preparaciones basadas en fibrinógeno y polisacáridos sulfatados - Google Patents

Preparaciones basadas en fibrinógeno y polisacáridos sulfatados

Info

Publication number
CO6400200A2
CO6400200A2 CO11085990A CO11085990A CO6400200A2 CO 6400200 A2 CO6400200 A2 CO 6400200A2 CO 11085990 A CO11085990 A CO 11085990A CO 11085990 A CO11085990 A CO 11085990A CO 6400200 A2 CO6400200 A2 CO 6400200A2
Authority
CO
Colombia
Prior art keywords
fibrinogen
sulfated
polysacarids
preparations based
present
Prior art date
Application number
CO11085990A
Other languages
English (en)
Inventor
Michael Dockal
Hans Christian Hedrich
Andreas Goppelt
Friedrich Scheiflinger
Klaus Tschetschokowitsch
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of CO6400200A2 publication Critical patent/CO6400200A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención provee una preparación que contiene fibrinógeno y un polisacárido sulfatado como una composición de un solo componente o como un kit de partes que contienen fibrinógeno y polisacárido sulfatado como componentes separados. La presente invención provee además una estructura tipo coágulo de fibrina, obtenible por un proceso definido, un parche hemostásico, un sistema de jeringa de dos componentes y varios usos de las preparaciones descritas, estructuras tipo coágulo de fibrina y parches.
CO11085990A 2008-12-11 2011-07-11 Preparaciones basadas en fibrinógeno y polisacáridos sulfatados CO6400200A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12180808P 2008-12-11 2008-12-11

Publications (1)

Publication Number Publication Date
CO6400200A2 true CO6400200A2 (es) 2012-03-15

Family

ID=42035771

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11085990A CO6400200A2 (es) 2008-12-11 2011-07-11 Preparaciones basadas en fibrinógeno y polisacáridos sulfatados

Country Status (13)

Country Link
US (1) US9566364B2 (es)
EP (1) EP2358402A2 (es)
JP (1) JP5746041B2 (es)
KR (1) KR101678241B1 (es)
CN (1) CN102307600B (es)
AR (1) AR081227A1 (es)
AU (1) AU2009324297B2 (es)
BR (1) BRPI0922524B8 (es)
CA (1) CA2746257C (es)
CO (1) CO6400200A2 (es)
MX (1) MX2011006255A (es)
TW (1) TWI488662B (es)
WO (1) WO2010066869A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011025957A2 (en) * 2009-08-28 2011-03-03 Ecole Polytechnique Federal De Lausanne Tg-aprotinin fusion proteins and matrices thereof
US10022410B2 (en) 2010-12-22 2018-07-17 Ethicon, Inc. Hemostatic preparation containing an extract of golden moss
US9446166B2 (en) * 2013-01-24 2016-09-20 Ethicon, Inc. Fibrin sealant compositions with chemical crosslinking
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
CN105147722A (zh) * 2015-09-17 2015-12-16 广州赛莱拉干细胞科技股份有限公司 硫酸化白芨多糖的新用途及一种治疗眼表损伤的制剂
KR20180027126A (ko) * 2016-09-06 2018-03-14 (주)한국비엠아이 가교화 히알루론산 유도체 매트릭스가 포함된 지혈 조성물
USD918654S1 (en) 2019-06-06 2021-05-11 Sharkninja Operating Llc Grill plate
SE1950885A1 (en) * 2019-07-11 2021-01-12 Faelker Knut Treatment of patients undergoing antiplatelet medication experiencing acute bleeding complications during / after surgery
CN111760066B (zh) * 2020-06-09 2022-03-04 北京化工大学 一种止血凝胶及其制备方法和应用
CN115785478B (zh) * 2022-10-12 2023-08-22 浙江大学 一种双网络纤维蛋白凝胶及其制备方法和应用
KR102565364B1 (ko) 2023-04-04 2023-08-09 김재열 자가골 회복 촉진용 조성물을 포함하는 서방성 국소 약물전달체 및 이를 포함하는 약학적 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT3699B (es) 1899-08-14 1901-03-26 Gilbert Wright
AT359652B (de) 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359653B (de) 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
AT398079B (de) 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
US5942278A (en) 1993-03-31 1999-08-24 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
ATE244584T1 (de) 1995-01-16 2003-07-15 Baxter Int Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
DE19617369A1 (de) 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6733774B2 (en) 2001-01-25 2004-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US7052713B2 (en) 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US6773699B1 (en) 2001-10-09 2004-08-10 Tissue Adhesive Technologies, Inc. Light energized tissue adhesive conformal patch
US20040101546A1 (en) 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20040126881A1 (en) 2002-09-06 2004-07-01 Vincent Ronfard Fibrin cell supports and methods of use thereof
PT1748781E (pt) * 2004-05-27 2013-01-22 Baxter Int Processos para o tratamento de distúrbios de hemorragias utilizando polissacarídeos sulfatados
US20070110813A1 (en) * 2005-11-02 2007-05-17 Aeris Therapeutics, Inc. Polycation-polyanion complexes, compositions and methods of use thereof
CN1788802A (zh) 2005-12-14 2006-06-21 温州医学院 促创伤修复生物海绵材料及其制备方法
CN100404080C (zh) * 2006-03-24 2008-07-23 清华大学 一种基于仿生过程的水凝胶快速成形工艺方法

Also Published As

Publication number Publication date
AU2009324297A1 (en) 2011-07-21
US9566364B2 (en) 2017-02-14
BRPI0922524B1 (pt) 2021-01-12
AU2009324297B2 (en) 2013-12-05
US20100166834A1 (en) 2010-07-01
CA2746257C (en) 2018-01-16
WO2010066869A2 (en) 2010-06-17
AR081227A1 (es) 2012-07-18
BRPI0922524B8 (pt) 2021-06-22
KR20110106345A (ko) 2011-09-28
TW201032838A (en) 2010-09-16
AU2009324297A2 (en) 2011-08-04
JP2012511548A (ja) 2012-05-24
MX2011006255A (es) 2012-01-20
CN102307600A (zh) 2012-01-04
TWI488662B (zh) 2015-06-21
EP2358402A2 (en) 2011-08-24
JP5746041B2 (ja) 2015-07-08
WO2010066869A3 (en) 2010-12-02
KR101678241B1 (ko) 2016-11-21
CA2746257A1 (en) 2010-06-17
CN102307600B (zh) 2015-11-25
BRPI0922524A2 (pt) 2020-08-11

Similar Documents

Publication Publication Date Title
CO6400200A2 (es) Preparaciones basadas en fibrinógeno y polisacáridos sulfatados
CR20110216A (es) Derivados de ácido 1-amino-2-ciclobutiletilborónico
ECSP088152A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
AR047928A1 (es) Derivados de tetrahidropiridoindol
EA201001555A1 (ru) Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17
ECSP099685A (es) Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
SV2011003855A (es) Heteroarilos sustituidos
ECSP12011939A (es) Compuestos Lipopéptidos y métodos relacionados
CR8529A (es) Nueva forma cristalina v de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contiene
UA112281C2 (uk) Стабільні інсектицидні композиції і способи їх отримання
CU20080028A6 (es) Compuestos químicos obtenidos in silico para la preparación de composiciones farmacéuticas para atenuar o inhibir la infección por virus dengue y otros flavivirus
BRPI0720153A8 (pt) Composições e artigos que contêm uma matriz de polímero reticulada e um líquido ativo imobilizado assim como processos de utilização dos mesmos
AR066395A1 (es) Reovirus que tienen secuencias modificadas
CR11251A (es) Depsipeptidos ciclicos y usos de los mismos
BRPI1013259B8 (pt) moduladores lxr
ECSP088884A (es) Compuestos heterociclicos fusionados y su uso como moduladores de mglur5
BRPI0719277A2 (pt) Formulação fitossanitária concentrada, utilização da formulação e composição solvente compreendendo uma mistura de solventes
HN2009000566A (es) Nuevos derivados de diosmetina, su procedimiento de prearacion y las composiciones farmaceuticas que lo contienen.
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
EA201390612A1 (ru) Биоразлагаемая композиция для доставки лекарственного средства
EA201290938A1 (ru) Конъюгированный фактор свертывания крови viii
HN2011002578A (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad clucocorticoide.
DK1976538T3 (da) Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre
CL2008001280A1 (es) Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano.

Legal Events

Date Code Title Description
FC Application refused